1. Elizabeth Tallett Joins Moderna’s Board of Directors

    Elizabeth Tallett Joins Moderna’s Board of Directors

    Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Elizabeth Tallett has joined its Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

    1. As Moderna approaches advanced stages of clinical development across our programs, we are focused on strengthening our board with industry leaders who understand the complexity of building companies to make a positive impact on patients.
    2. I am delighted to be joining Moderna's board at such a unique point in its history, as it rapidly moves towards commercialization of its first products and starts to fulfill its mission of creating a new class of life-saving mRNA medicines and vaccines.
    3. As we prepare for late-stage development of our COVID-19 vaccine and our CMV vaccine, we sought a director with diverse experience leading companies poised for growth.
  3. Topics Mentioned